August 12, 2026 · 2 min read

DSIP: the delta sleep-inducing peptide and why researchers call it an unresolved riddle

DSIP was isolated in 1977 as a possible sleep factor. A look at why decades later its natural role, receptor and link to sleep are still unclear.

Delta sleep-inducing peptide, or DSIP, is a short peptide that a group in Basel isolated from rabbit cerebral venous blood in 1977. It was first regarded as a candidate sleep-promoting factor, and the name stuck. What is unusual about DSIP is how little has been settled since.

The DSIP sequence

Hydrophobic
Glycine or proline
Negatively charged
Polar

Length: 9 amino acids
Average mass: 848.8 Da
Formula: C35H48N10O15

Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. Sequence and average mass checked against PubChem (CID 68816).

What the 2006 review says

A 2006 mini-review in the Journal of Neurochemistry titled "a still unresolved riddle" is blunt. It says the link between DSIP and sleep was never characterized, partly because the gene, the protein and a possible receptor were never isolated, and calls the hypothesis that DSIP is a sleep factor extremely poorly documented. DSIP-like immunoreactivity is found in hypothalamic nuclei that aren't especially involved in sleep regulation, and the molecule has a broad spectrum of biological activity in vitro.

What is still unsettled about DSIP

Link to sleep
Never further characterized; the sleep-factor idea is described as poorly documented and weak.
Gene, protein, receptor
The DSIP gene, its protein and a possible receptor were never isolated.
Natural occurrence
Its natural occurrence and biological activity remain obscure.
Structure
Different from any known peptide family.

Points raised in the mini-review by Kovalzon and Strekalova, J Neurochem 2006.

An alternative hypothesis

The authors propose that a DSIP-like peptide, or several, may be responsible for at least part of the immunoreactivity and activity attributed to DSIP. They point to evidence that certain artificial structural analogues, but notably not DSIP itself, promoted slow-wave sleep in rabbits and rats in their early studies. They also cite a naturally occurring dermorphin decapeptide that is structurally similar to DSIP at five of nine positions and promoted slow-wave sleep in rabbits.

Reviews from 1984 and 1986 and one from 2001 in an anesthesia journal are listed below for the earlier literature. They are worth reading next to the 2006 paper to see how the field's confidence changed.

The reasoning behind a DSIP-like peptide

1
Location
DSIP-like immunoreactivity sits in hypothalamic nuclei not especially tied to sleep regulation.
2
Breadth
Biochemical and physiological studies in vitro show a large spectrum of DSIP activity.
3
Analogues
Certain artificial analogues, but not DSIP itself, promoted slow-wave sleep in rabbits and rats.
4
Dermorphin
A natural decapeptide similar to DSIP at five of nine positions promoted slow-wave sleep in rabbits.

The four observations the 2006 mini-review uses to support its hypothesis (Kovalzon and Strekalova, J Neurochem 2006).

What a researcher should take from it

DSIP is a case where decades of use in experiments haven't produced a clear biological story. If you read a source that states DSIP improves sleep, check whether it cites a controlled study or only these older reviews. For lab work, reproducibility is also hard when so little is known about what the compound is meant to do.